Fauci privately raised concerns about COVID vaccines for pregnant women
Fox News chief congressional correspondent Chad Pergram reports on newly released text messages showing Dr. Anthony Fauci privately raising concerns about COVID mRNA vaccines for pregnant women on ‘The Evening Edit.’
VA tests GLP-1 therapy to combat veteran addiction, Doug Collins reveals
VA Secretary Doug Collins discusses a groundbreaking new trial testing GLP-1 therapies, like those used for weight loss, to help veterans overcome substance abuse and addiction.
VA secretary: 'Freedom Haulers' initiative a 'wonderful way' to help economy and veterans
U.S. Secretary of Veteran Affairs Doug Collins discusses the VA's test of new GLP-1 therapy, the 'Freedom Haulers' initiative and efforts to cut red tape and more on 'Mornings with Maria.'
AI is transforming healthcare, and the benefits are only growing: Dr. Peter Fleischut
NewYork-Presbyterian Executive Vice President Dr. Peter Fleischut discusses how AI is improving patient care, enhancing clinical decision-making, transforming anesthesia and shaping the future of medicine on 'Mornings with Maria.'
AI is the 'ultimate physician extender,' orthopedic surgeon says
Orthopedic surgeon Dr. Andrew D. Pearle discusses how AI is transforming sports medicine, the development of digital twins of joints and how the Hospital for Special Surgery (HSS) is applying AI medical technology to improve patient care.
Full spectrum of traditional healthcare will see a 'transformation' from AI, doctor says
Johns Hopkins Health System Vice President of Clinical Innovation Dr. Peter A. Najjar explains the transformative impact of AI in the medical fields and the application of the technology for oncology and cancer patients on 'Mornings with Maria.
Tom Brady teams with digital health firm eMed to expand GLP-1 weight loss medication access
NFL legend Tom Brady is partnering with eMed to tackle the obesity epidemic by making GLP-1 weight loss medications accessible through employer health benefits.
Pfizer CEO on primary care, GLP-1 outlook and innovation timeline
Albert Bourla, Pfizer Chairman & CEO, discusses strong performance in primary care and the game-changing Metsera acquisition for GLP-1 set to launch by 2028 on 'Mornings with Maria.'
AI will be 'transformational' in drug development and discovery, Pfizer CEO says
Pfizer CEO Albert Bourla details $70B US investment in manufacturing and R&D, discussing oncology advancements, the GLP-1 drug race, and AI's transformative role in drug development on 'Mornings with Maria.'
The overlooked reason why new drugs take so long—and the $10 trillion fix
A new report estimates speeding up FDA drug approvals by one year could generate over $10 trillion in economic value from faster medical innovation.
Johnson & Johnson CEO credits Trump tax policy for $55B US investment push, including $1B in Florida
Johnson & Johnson says favorable tax policies, a skilled workforce and a strong investment climate helped drive its $55 billion commitment to U.S. manufacturing and research.
Philips North America CEO reveals how AI impacts healthcare efficiency
Philips North America CEO Jeff DiLullo discusses the 2026 Future Health Index explaining how AI is reshaping healthcare on 'Varney & Co.'
Wall Street makes massive bet on blood-based cancer testing
Natera co-founder Matthew Rabinowitz details the company’s pioneering work in AI-driven cancer detection on ‘Maria Bartiromo’s Wall Street.’
Trulieve CEO says medical cannabis reclassification a 'giant step forward for American healthcare'
Trulieve founder and CEO Kim Rivers discusses the impact of Trump's administration reclassifying state-licensed medical cannabis from Schedule 1 to Schedule 3 on 'Varney & Co.'
Medical device giant hit by global network disruption after cyberattack possibly linked to pro-Iranian group
Medical device giant Stryker was hit by cyberattack on Wednesday. A pro-Iranian hacktivist group allegedly claimed responsibility for the breach.
Reclassifying marijuana as a Schedule III drug opens door to medical research into its ‘positive attributes’
Green Thumb Industries founder and CEO Ben Kovler breaks down the White House’s potential move to reclassify marijuana from Schedule I to Schedule III on ‘The Claman Countdown.’
FDA commissioner unveils major reform to fast-track drug innovation
FDA Commissioner Dr. Marty Makary joins 'Varney & Co.' to discuss the FDA's plan to cut red tape, declining men's testosterone levels and his visit to Novartis' manufacturing site.
Jimmy V Week celebrates coach Valvano’s lasting legacy and fuels continued fight against cancer
Jimmy V Week honors Jim Valvano’s inspiring legacy and his foundation’s mission to fight cancer, uniting fans and athletes through hope, perseverance, and teamwork.
Pfizer wins 'fantastic deal' after $10B obesity drug fight with Novo Nordisk
Pfizer Chairman and CEO Albert Bourla joins 'Mornings with Maria' to discuss the company’s $10 billion acquisition of obesity drug startup Metsera, its competition with Novo Nordisk and his plans to expand their weight-loss drug pipeline.
Neuralink submits patient data for publishing
Fox News senior medical analyst Dr. Marc Siegel joins 'Varney & Co.' to discuss Neuralink’s newly submitted data and the connection between faith and healing in his new book 'The Miracles Among Us.'